These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16513626)

  • 1. A highly sensitive thyroglobulin assay has superior diagnostic sensitivity for recurrence of differentiated thyroid cancer in patients undergoing TSH suppression.
    Zöphel K; Wunderlich G; Kotzerke J
    J Nucl Med; 2006 Mar; 47(3):552-3; author reply 553. PubMed ID: 16513626
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning.
    Ma C; Kuang A; Xie J; Ma T
    J Nucl Med; 2005 Sep; 46(9):1473-80. PubMed ID: 16157530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detectable thyroglobulin with negative imaging in differentiated thyroid cancer patients. What to do with negative anatomical imaging and radioiodine scan?
    Giovanella L; Treglia G; Ceriani L; Verburg F
    Nuklearmedizin; 2014; 53(1):1-10. PubMed ID: 24305950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should high hTg levels in the absence of iodine uptake be treated?
    Britton KE; Foley RR; Chew SL
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):794-5. PubMed ID: 12616324
    [No Abstract]   [Full Text] [Related]  

  • 5. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
    Ma C; Xie J; Kuang A
    J Nucl Med; 2005 Jul; 46(7):1164-70. PubMed ID: 16000286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should high hTg levels in the absence of iodine uptake be treated?
    Biermann M; Schober O
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):160-3. PubMed ID: 12583404
    [No Abstract]   [Full Text] [Related]  

  • 8. Should high hTg levels in the absence of iodine uptake be treated?
    Lind P
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):157-60. PubMed ID: 12583362
    [No Abstract]   [Full Text] [Related]  

  • 9. False-positive "necklace sign" on whole-body thyroid cancer survey--a case report.
    Beaulieu S; Djang D; Minoshima S
    J Nucl Med Technol; 2005 Mar; 33(1):42-3. PubMed ID: 15731020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic accuracy of 18F-FDG PET in residual or recurrent differentiated thyroid carcinoma with high thyroglobulin and negative 131-I whole-body scan].
    Cabrera Martín MN; Pasamontes Pingarrón JA; Carreras Delgado JL; Lapeña Gutiérrez L; Delgado Bolton RC; Bittini Copano A; Pérez Castejón MJ; Fernández Pérez C
    Rev Esp Med Nucl; 2007; 26(5):263-9. PubMed ID: 17910834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful thyroid tissue ablation as defined by a negative whole-body scan or an undetectable thyroglobulin: a comparative study.
    Karam M; Feustel PJ; Postal ES; Cheema A; Goldfarb CR
    Nucl Med Commun; 2005 Apr; 26(4):331-6. PubMed ID: 15753792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory follow-up in differentiated thyroid carcinoma.
    Maussier ML; Danese D; D'Errico G; Garganese MC; Pontecorvi A; Lemmo G
    Rays; 2000; 25(2):239-44. PubMed ID: 11370541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma].
    Rosário PW; Fagundes TA; Purisch S; Padrão EL; Rezende LL; Barroso AL
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):350-8. PubMed ID: 16543988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
    Giusti M; Zoccola R; Guazzini B; Molinari E; Valenti S; Villa G; Bertolazzi L; Minuto F
    Minerva Endocrinol; 2003 Sep; 28(3):191-203. PubMed ID: 14605601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic I-131 scintigraphy in patients with differentiated thyroid cancer: no additional value of higher scan dose.
    Phan TT; van Tol KM; Links TP; Piers DA; de Vries EG; Dullaart RP; Jager PL
    Ann Nucl Med; 2004 Dec; 18(8):641-6. PubMed ID: 15682843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 18fluoro-2-deoxyglucose positron emission tomography in iodine scan negative, differentiated thyroid cancer recurrence.
    Chisholm EJ; Tolley NS
    J Laryngol Otol; 2009 Oct; 123(10):1145-9. PubMed ID: 19607742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET and alternative imaging in the management of thyroid carcinoma.
    Al-Nahhas AM
    Nucl Med Rev Cent East Eur; 2003; 6(2):139-45. PubMed ID: 14737730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
    Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
    Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.